miR-223 overexpression inhibits doxorubicin-induced autophagy by targeting FOXO3a and reverses chemoresistance in hepatocellular carcinoma cells

Zhou, Y; Chen, EJ; Tang, YX; Mao, JY; Shen, J; Zheng, XX; Xie, SZ; Zhang, SF; Wu, Y; Liu, H; Zhi, X; Ma, T; Ni, HB; Chen, JB; Chai, KQ; Chen, W

Chai, KQ; Chen, W (reprint author), Zhejiang Acad Tradit Chinese Med, Canc Inst Integrated Tradit Chinese & Western Med, Key Lab Canc Prevent & Therapy Combining Tradit C, Hangzhou 310012, Zhejiang, Peoples R China.; Chai, KQ; Chen, W (reprint author), To

CELL DEATH & DISEASE, 2019; 10 ():

Abstract

Doxorubicin is conventionally used in chemotherapy against hepatocellular carcinoma (HCC), but acquired resistance developed during long-term therapy ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索